MedTrace Logo

Effect of Octreotide on the Colonic Motility in Pediatric Patients

NCT01917773 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2015-12-21

Study results available
· View outcomes & findings →

Summary

The research study is designed to test how a medication called octreotide affects the motility (contraction or squeezing) of the colon (large intestine). Investigators are investigating whether octreotide can increase contraction and movement in the colon.

Conditions

Interventions

DRUG

Octreotide

Average MI for all patients was calculated over 15-minutes, 30-minutes and 45- minutes before and after administration of octreotide

DRUG

Bisacodyl

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Joseph Croffie · Riley Hospital for Children

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917773 on ClinicalTrials.gov